Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 81 results.
User Information
Export Records
  1. 1.   In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells
  2. Bissa, Massimiliano; Galli, Veronica; Schifanella, Luca; Vaccari, Monica; Rahman, Mohammad Arif; Gorini, Giacomo; Binello, Nicolò; Sarkis, Sarkis; Gutowska, Anna; Silva de Castro, Isabela; Doster, Melvin N; Moles, Ramona; Ferrari, Guido; Shen, Xiaoying; Tomaras, Georgia D; Montefiori, David C; N'guessan, Kombo F; Paquin-Proulx, Dominic; Kozlowski, Pamela A; Venzon, David J; Choo-Wosoba, Hyoyoung; Breed,Matthew; Kramer,Josh; Franchini, Genoveffa
  3. Vaccines. 2023, Oct 30; 11(11):
  1. 2.   Transplantation of CCR5 Delta 32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
  2. Rothenberger, Meghan; Wagner, John E; Haase, Ashley; Richman, Douglas; Grzywacz, Bartosz; Strain, Matthew; Lada, Steven; Estes, Jake; Fletcher, Courtney V; Podany, Anthony T; Anderson, Jodi; Schmidt, Thomas; Wietgrefe, Steve; Schacker, Timothy; Verneris, Michael R
  3. Open forum infectious diseases. 2018, May; 5(5): ofy090.
  1. 3.   Host genetic variation and HIV disease: from mapping to mechanism
  2. Naranbhai, Vivek; Carrington, Mary
  3. Immunogenetics. 2017, Aug; 69(8-9): 489-498.
  1. 4.   Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia
  2. An, P.; Li, R. L.; Wang, J. M.; Yoshimura, T.; Takahashi, M.; Samudralal, R.; O'Brien, S. J.; Phair, J.; Goedert, J. J.; Kirk, G. D.; Troyer, J. L.; Sezgin, E.; Buchbinder, S. P.; Donfield, S.; Nelson, G. W.; Winkler, C. A.
  3. Plos Genetics. 2011, Oct; 7(10): 10.
  1. 5.   Neurotrophins modulate the expression of chemokine receptors in the brain
  2. Avdoshina, V. A. V.; Becker, J.; Campbell, L. A.; Parsadanian, M.; Mhyre, T.; Tessarollo, L.; Mocchetti, I.
  3. Journal of Neurovirology. 2011, Feb; 17(1): 58-62.
  1. 6.   CCL5: A Double-Edged Sword in Host Defense Against the Hepatitis C Virus
  2. Katsounas, A.; Schlaak, J. F.; Lempicki, R. A.
  3. International Reviews of Immunology. 2011, Oct-Dec; 30(5-6): 366-378.
  1. 7.   TCR triggering transcriptionally downregulates CCR5 expression on rhesus macaque CD4(+) T-cells with no measurable effect on susceptibility to SIV infection
  2. Minang, J. T.; Trivett, M. T.; Barsov, E. V.; Del Prete, G. Q.; Trubey, C. M.; Thomas, J. A.; Gorelick, R. J.; Piatak, M.; Ott, D. E.; Ohlen, C.
  3. Virology. 2011, Jan; 409(1): 132-140.
  1. 8.   alpha 4(+)beta 7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection
  2. Kader, M.; Wang, X.; Piatak, M.; Lifson, J.; Roederer, M.; Veazey, R.; Mattapallil, J. J.
  3. Mucosal Immunology. 2009 2(5): 439-449.
  1. 9.   Topically Applied Recombinant Chemokine Analogues Fully Protect Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge
  2. Veazey, R. S.; Ling, B. H.; Green, L. C.; Ribka, E. P.; Lifson, J. D.; Piatak, M.; Lederman, M. M.; Mosier, D.; Offord, R.; Hartley, O.
  3. Journal of Infectious Diseases. 2009 199(10): 1525-1527.
  1. 10.   Recent progress in antiretrovirals - lessons from resistance
  2. Adamson, C. S.; Freed, E. O.
  3. Drug Discovery Today. 2008 13(9-10): 424-432.
  1. 11.   Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain
  2. Ahmed, F.; Tessarollo, L.; Thiele, C.; Mocchetti, I.
  3. Brain Research. 2008 1227: 1-11.
  1. 12.   Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges
  2. Ambrose, Z.; Compton, L.; Piatak, M.; Lu, D.; Alvord, W. G.; Lubomirski, M. S.; Hildreth, J.; Lifson, J. D.; Miller, C. J.; KewalRamani, V. N.
  3. Journal of Virology. 2008 82(13): 6591-6599.
  1. 13.   Interaction between RANTES Promoter Variant and CCR5 Delta 32 Favors Recovery from Hepatitis B
  2. Thio, C. L.; Astemborski, J.; Thomas, R.; Mosbruger, T.; Witt, M. D.; Goedert, J. J.; Hoots, K.; Winkler, C.; Thomas, D. L.; Carrington, M.
  3. Journal of Immunology. 2008 181(11): 7944-7947.
  1. 14.   Genetic protection against hepatitis B virus conferred by CCR5 Delta 32: Evidence that CCR5 contributes to viral persistence
  2. Thio, C. L.; Astemborski, J.; Bashirova, A.; Mosbruger, T.; Greer, S.; Witt, M. D.; Goedert, J. J.; Hilgartner, M.; Majeske, A.; O'Brien, S. J.; Thomas, D. L.; Carrington, M.
  3. Journal of Virology. 2007, Jan; 81(2): 441-445.
  1. 15.   Polymorphisms in eight host genes associated with control of HIV replication do not mediate elite control of viral replication in SIV-infected Indian rhesus macaques
  2. Weiler, A.; May, G. E.; Qi, Y.; Wilson, N.; Watkins, D. I.
  3. Immunogenetics. 2006, Dec; 58(12): 1003-1009.
  1. 16.   Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration
  2. Choudhry, V.; Zhang, M. Y.; Harris, I.; Sidorov, I. A.; Vu, B.; Dimitrov, A. S.; Fouts, T.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2006, Sep; 348(3): 1107-1115.
  1. 17.   Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV type 1 transmission and AIDS disease progression
  2. Modi, W. S.; Lautenberger, J.; An, P.; Scott, K.; Goedert, J. J.; Kirk, G. D.; Buchbinder, S.; Phair, J.; Donfield, S.; O'Brien, S. J.; Winkler, C.
  3. American Journal of Human Genetics. 2006, Jul; 79(1): 120-128.
  1. 18.   Adenosine A2a receptors induce heterologous desensitization of chemokine receptors
  2. Zhang, N.; Yang, D.; Dong, H. F.; Chen, Q.; Dimitrova, D. I.; Rogers, T. J.; Sitkovsky, M.; Oppenheim, J. J.
  3. Blood. 2006, Jul; 108(1): 38-44.
  1. 19.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 20.   Genetic variations in CC chemokine receptors and hypertension
  2. Zhang, M. D.; Ardlie, K.; Wacholder, S.; Welch, R.; Chanock, S.; O'Brien, T. R.
  3. American Journal of Hypertension. 2006, Jan; 19(1): 67-72.
  1. 21.   Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population
  2. Petersen, D. C.; Glashoff, R. H.; Shrestha, S.; Bergeron, J.; Laten, A.; Gold, B.; van Rensburg, E. J.; Dean, M.; Hayes, V. M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 521-526.
  1. 22.   The case for selection at CCR5-Delta 32
  2. Sabeti, P. C.; Walsh, E.; Schaffner, S. F.; Varilly, P.; Fry, B.; Hutcheson, H. B.; Cullen, M.; Mikkelsen, T. S.; Roy, J.; Patterson, N.; Cooper, R.; Reich, D.; Altshuler, D.; O'Brien, S.; Lander, E. S.
  3. Plos Biology. 2005, NOV; 3(11): 1963-1969.
  1. 23.   Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression
  2. Daar, E. S.; Lynn, H. S.; Donfield, S. M.; Lail, A.; O'Brien, S. J.; Huang, W.; Winkler, C. A.
  3. Journal of Infectious Diseases. 2005, NOV 1; 192(9): 1597-1605.
  1. 24.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 25.   Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5
  2. Dong, H. F.; Wigmore, K.; Carrington, M. N.; Dean, M.; Turpin, J. A.; Howard, O. M. Z.
  3. Genes and Immunity. 2005, OCT; 6(7): 609-619.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel